Keyphrases
Epilepsy
100%
Mammalian Target of Rapamycin Inhibition
100%
Epileptogenesis
100%
Therapeutic Role
100%
Mammalian Target of Rapamycin (mTOR)
75%
MTOR Inhibitor
75%
Antiepileptogenic
75%
Tuberous Sclerosis Complex
50%
Dysregulation
50%
Acquired Epilepsy
50%
Trauma
25%
Medical Therapy
25%
Signaling Molecules
25%
Brain Injury
25%
Recent Advances
25%
Genetic Causes
25%
Rapamycin
25%
New Therapies
25%
Hyperactivity
25%
Clinical Utility
25%
Treatment Modalities
25%
Brain Tumor
25%
New Drug Targets
25%
Underlying Disease
25%
Cellular Changes
25%
Genetic mutation
25%
Ketogenic Diet
25%
Genetic Epilepsy
25%
Seizure Activity
25%
Regulatory Molecules
25%
Brain Pathology
25%
Status Epilepticus
25%
Focal Cortical Dysplasia
25%
Mammalian Target of Rapamycin Signaling Pathway
25%
Final Common Pathway
25%
Number of Treatment
25%
Spontaneous Seizures
25%
Causes of Epilepsy
25%
Antiepileptogenesis
25%
Pathogenic Changes
25%
Medicine and Dentistry
Mechanistic Target of Rapamycin
100%
Epileptogenesis
100%
Mammalian Target of Rapamycin Inhibitor
42%
Epileptic Seizure
28%
Tuberous Sclerosis
28%
Injury
14%
Gene Mutation
14%
Combination Therapy
14%
Brain Injury
14%
Signaling Molecule
14%
Cortical Dysplasia
14%
Cell Signaling Pathway
14%
Excitement
14%
Rapamycin
14%
Ketogenic Diet
14%
Hyperactivation
14%
Status Epilepticus
14%
Intracranial Tumor
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mammalian Target of Rapamycin
100%
Epileptogenesis
100%
Mammalian Target of Rapamycin Inhibitor
42%
Tuberous Sclerosis
28%
Combination Therapy
14%
Injury
14%
Brain Injury
14%
Rapamycin
14%
Epileptic State
14%
Cortical Dysplasia
14%
Intracranial Tumor
14%
Diseases
14%
Neuroscience
Mammalian Target of Rapamycin
100%
Epileptogenesis
100%
Tuberous Sclerosis
20%
Cell Signaling
10%
Gene Mutation
10%
Ketogenic Diet
10%
Status Epilepticus
10%
Cell Excitability
10%
Dysplasia
10%
Intracranial Tumor
10%
Sirolimus
10%